Globus Medical (NYSE: GMED) reported Q4 EPS of $0.30, $0.05 better than the analyst estimate of $0.25. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $127.77 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.